Submitted by Anonymous (not verified) on 25 August 2023 - 10:12
Human medicines European public assessment report (EPAR): Regkirona, regdanvimab, COVID-19 virus infection, Date of authorisation: 12/11/2021, Revision: 8, Status: Authorised
Source: